Welcome to our dedicated page for West Pharm Svcs news (Ticker: WST), a resource for investors and traders seeking the latest updates and insights on West Pharm Svcs stock.
West Pharmaceutical Services, Inc. (NYSE: WST) provides injectable drug administration solutions and services for pharmaceutical, biotechnology and generic drug customers. Its business includes elastomer-based packaging components such as stoppers, seals and plungers, nonglass containment technologies, auto-injectors and contract services for device manufacturing, assembly, packaging, validation, analytical testing and regulatory support.
News about West commonly covers quarterly results, revenue guidance, Proprietary Products and Contract Manufacturing performance, capacity additions for high-volume injectable therapies, and demand tied to biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. Other recurring developments include dividends, share repurchase authorizations, investor conference participation and governance or executive-transition updates.
West Pharmaceutical Services reported Q2 2020 net sales of $527.2 million, a 12.2% increase, with organic sales growth at 14.3%. The diluted EPS rose by 38% to $1.21, with adjusted diluted EPS up 40% to $1.25. The company raised its full-year guidance for net sales to between $2.035 billion and $2.055 billion, and adjusted diluted EPS to $4.15 to $4.25. Strong demand in proprietary and contract-manufactured products, particularly for healthcare devices, bolstered the results.
West Pharmaceutical Services, Inc. (NYSE: WST) announced a dividend of $0.16 per share for the third quarter of 2020. The dividend is scheduled for payment on August 5, 2020, to shareholders of record as of July 29, 2020. This decision underscores the company’s commitment to returning value to its shareholders while continuing its operations in innovative solutions for injectable drug administration.
West Pharmaceutical Services, a leader in injectable drug administration solutions, will reveal its second-quarter 2020 financial results on July 23, 2020, before the market opens. A conference call is scheduled for 9:00 a.m. Eastern Time on the same day to discuss the results and business outlook. Interested participants can join the call by dialing 877-930-8295 or 253-336-8738 for international access, using conference ID 7789173. A live broadcast will also be available on the company’s website.